Lim A Young, Song Ju Sun, Kim Eun Kyoung, Jang Shin Yi, Chung Tae-Young, Choi Seung-Hyuk, Sung Kiick, Huh June, Kang I-Seok, Choe Yeon Hyeon, Ki Chang-Seok, Kim Duk-Kyung
Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Korean Circ J. 2016 Nov;46(6):841-845. doi: 10.4070/kcj.2016.46.6.841. Epub 2016 Oct 24.
Marfan syndrome (MFS) is a connective tissue disorder with autosomal dominant inheritance and a highly variable clinical spectrum. However, there are limited data available on the clinical features of Korean patients with MFS. The aim of the present study was to describe the clinical characteristics and outcomes of Korean patients with MFS.
We included all patients who were diagnosed with MFS between January 1995 and May 2015 at a single tertiary medical center. Patients with an MFS-related disorder including MASS phenotype (myopia, mitral valve prolapse, borderline and non-progressive aortic root dilatation, skeletal findings, and striae), mitral valve prolapse syndrome, and ectopia lentis syndrome were excluded. A total of 343 Korean patients aged ≥15 years who satisfied the revised Ghent nosology were included.
The mean patient age at diagnosis was 35.9±12.6 years and 172 (50.1%) patients were male. Median follow-up duration was 52.8 months. A total of 303 patients (88.6%) had aortic root dilatation with Z score ≥2 or aortic root dissection. Ectopia lentis was relatively less common (163 patients, 55.1%) and systemic score ≥7 was found in 217 patients (73.8%). Among 219 probands, a family history of MFS was present in 97 patients (44.5%) and sporadic cases in 121 patients (55.5%). Among the 157 probands who underwent genetic analysis, 141 (89.8%) had an mutation associated with aortic root aneurysm/dissection. Aortic dissection (AD) or intramural hematoma (IMH) was identified in 110 patients (32.1%). Among the 221 patients without AD or IMH, descending aortic aneurysms were identified in 19 patients (8.6%). Two hundred thirteen patients (62%) underwent cardiovascular surgery of any type. Eight patients died during follow-up.
We described the clinical characteristics and outcomes of Korean MFS patients. Cardiovascular manifestations were commonly detected and mutation was present in approximately 90% of patients. In contrast, ectopia lentis was identified in approximately half of patients. Our findings will be informative for the evaluation of patients with MFS.
马凡综合征(MFS)是一种常染色体显性遗传的结缔组织疾病,临床谱高度可变。然而,关于韩国马凡综合征患者的临床特征,现有数据有限。本研究旨在描述韩国马凡综合征患者的临床特征及预后。
我们纳入了1995年1月至2015年5月期间在一家三级医疗中心被诊断为马凡综合征的所有患者。排除患有与马凡综合征相关疾病的患者,包括MASS表型(近视、二尖瓣脱垂、临界性和非进行性主动脉根部扩张、骨骼表现及皮肤条纹)、二尖瓣脱垂综合征和晶状体异位综合征。共纳入343名年龄≥15岁且符合修订版根特分类法的韩国患者。
患者诊断时的平均年龄为35.9±12.6岁,172名(50.1%)患者为男性。中位随访时间为52.8个月。共有303名患者(88.6%)出现主动脉根部扩张,Z值≥2或主动脉根部夹层。晶状体异位相对较少见(163名患者,55.1%),217名患者(73.8%)全身评分≥7。在219名先证者中,97名患者(44.5%)有马凡综合征家族史,121名患者(55.5%)为散发病例。在157名接受基因分析的先证者中,141名(89.8%)有与主动脉根部瘤/夹层相关的突变。110名患者(32.1%)被诊断为主动脉夹层(AD)或壁内血肿(IMH)。在221名无AD或IMH的患者中,19名患者(8.6%)发现降主动脉瘤。213名患者(62%)接受了任何类型的心血管手术。8名患者在随访期间死亡。
我们描述了韩国马凡综合征患者的临床特征及预后。心血管表现常见,约90%的患者存在突变。相比之下,约一半患者发现晶状体异位。我们的研究结果将为马凡综合征患者的评估提供参考。